| 查看: 627 | 回复: 7 | ||
| 【奖励】 本帖被评价4次，作者ludasheng-1增加金币 3.5 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)
|
||
 Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development) By Sayed S. Daoud Publisher: Humana Press Number Of Pages: 300 Publication Date: 2007-11-13 ISBN-10 / ASIN: 1588298582 ISBN-13 / EAN: 9781588298584 Binding: Hardcover This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actual clinical applications of proteomics in cancer therapy. Case studies in may tumor types are provided to show the feasibility of generating the critical information needed to individualization of therapy in cancer patients. The final part of the book provides in depth information on annotating the human proteome and the role of Food and Drug Administration (FDA) in regulating the use of proteomics in cancer therapy. To functionally annotate the human proteome, the Swiss Institute for Bioinformatics (SIB) and the European Bioinformatics Institute (EBI) initiated a major effort to distribute to the scientific community highly integrated information on human protein sequences. This initiative, which is called the Human Proteomics Initiative (HPI) aims to provide for each known human protein a wealth of information that include the description of its function, domain and protein family classification, subcellular location, posttranslational modifications, variants and similarities to other proteins. Integration of bioinformatics into clinical application of proteomics in cancer therapy is outlined as well as regulations and policy of commercial application of proteomics in patient care. Link: http://rapidshare.com/files/79603386/asd_Cancer_Proteomics.rar http://www.megaupload.com/?d=TSQS7G6L http://w15.easy-share.com/13439551.html http://depositfiles.com/files/2867982 http://rapidshare.com/files/7968 ... .bioXplorer.com.rar [search]Cancer Proteomics[/search] |
回复此楼» 猜你喜欢
应该是93bebmhtak前后十一个字符比较关键
已经有10人回复
-
这样的filecode谁见过
已经有21人回复
-
filecode与中标关系的预测
已经有5人回复
-
关于代码变化问题，想知道的进来
已经有17人回复
-
fileCode有新解读？
已经有18人回复
-
关于filecode，很负责任的告诉大家
已经有7人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
关于豆爷回答的JTJC与%2F数量
已经有7人回复
-
2026国自然放榜时间
已经有3人回复
-
国基金的申报应该改成非等额制，评价高的钱多评价低的钱少，但是增加资助率
已经有7人回复
3楼2007-12-30 09:07:34
2楼2007-12-30 05:54:04
4楼2007-12-30 09:30:31
5楼2008-02-21 21:28:54
20